Advanced Nanotechnology for Precision Theranostics of Cancer Stem Cells
ACS Nano · 2026
DOI: 10.1021/acsnano.6c11742 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, 2026. Verfasst von Fuming Liang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, China Medical Sc…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Theranostic Nanomedicine, Nanotechnology, Neoplasms. Die Arbeit nennt 226 Literaturangaben. Gefördert von: the National Key Research and Development Program of China, National Key R&D Program of China, Sichuan Science and Technology Program.
Abstract (Originalsprache)
Cancer stem cells (CSCs) represent a minor subpopulation of tumor cells located in deep tumor regions, which play pivotal roles in driving malignant progression, chemoresistance, and tumor recurrence. However, conventional CSC theranostic approaches suffer from insufficient targeting accuracy, limited tissue penetration capacity, and poor integration of diagnostic and therapeutic functions, which severely restrict their clinical outcomes. Accordingly, the development of highly specific and multifunctional nanoplatforms is urgently needed. On the one hand, advanced nanotechnology permits the efficient capture, enrichment and signal amplification of CSCs, thus significantly improving detection sensitivity, reducing the detection limit, and facilitating early tumor diagnosis and prognostic evaluation. On the other hand, nanotechnology can achieve deep tumor penetration and precise targeted delivery toward CSCs, offering a robust therapeutic strategy for eradicating tumors and preventing recurrence. In this review, we systematically summarize the biological characteristics of CSCs, elaborate the advanced nanotechnology-mediated strategies for precise enrichment and detection of CSCs, and lay a theoretical basis for the design of CSC-specific targeted nanotherapeutics. Furthermore, we discuss the key challenges for the clinical translation of CSC-oriented nanotheranostics, and anticipate that nanotechnology will bring promising advances for CSC-targeted cancer theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, China Medical School, Sichuan University and Collaborative Innovation Center for Bioth…
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore119074, Singapore.
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, New Cornerstone Science Laboratory, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing10…
ORCID-Profile: Fuming Liang, Jianguo Xu, Xiang Gao, Chunying Chen, Qing You
Förderung
- the National Key Research and Development Program of China
- National Key R&D Program of China
- Sichuan Science and Technology Program
- General Program of the National Natural Science Foundation of China
Zitieren
APA
Liang, F., Wu, G., Xu, J., Gao, X., Chen, C., & You, Q. (2026). Advanced Nanotechnology for Precision Theranostics of Cancer Stem Cells. ACS Nano. https://doi.org/10.1021/acsnano.6c11742
Vancouver
Liang F, Wu G, Xu J, Gao X, Chen C, You Q. Advanced Nanotechnology for Precision Theranostics of Cancer Stem Cells. ACS Nano. 2026. doi:10.1021/acsnano.6c11742
BibTeX
@article{Liang2026,
author = {Liang, Fuming and Wu, Gege and Xu, Jianguo and Gao, Xiang and Chen, Chunying and You, Qing},
title = {Advanced Nanotechnology for Precision Theranostics of Cancer Stem Cells},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c11742}
}
EUVIMED